1	Administrar	administrar	VMN0000	C1621583	calificador	0-11	651_ANS_clinical_caseMIR	SENT1	-	-
2	una	una		C0205447_1	calificador_1	12-15	651_ANS_clinical_caseMIR	SENT1	-	-
3	dosis	dosis	NCFN000	-	-	16-21	651_ANS_clinical_caseMIR	SENT1	-	-
4	de	de	SPS00	C0332285	atributo	22-24	651_ANS_clinical_caseMIR	SENT1	-	-
5	gammaglobulina	gammaglobulina	NCFS000	C0017007	sustancia	25-39	651_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
6	frente	frente	RG	C1284847#C0016540#C0549224	estructura_corporal	40-46	651_ANS_clinical_caseMIR	SENT1	-	-
7	a	a	SPS00	-	-	47-48	651_ANS_clinical_caseMIR	SENT1	-	-
8	VHB	virus_de_la_hepatitis_b	NC00YL0	-	-	49-52	651_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
9	y	y	CC	C1706368	calificador	53-54	651_ANS_clinical_caseMIR	SENT1	-	-
10	una	una		C0205447_1	calificador_1	55-58	651_ANS_clinical_caseMIR	SENT1	-	-
11	dosis	dosis	NCFN000	-	-	59-64	651_ANS_clinical_caseMIR	SENT1	-	-
12	de	de	SPS00	C0332285	atributo	65-67	651_ANS_clinical_caseMIR	SENT1	-	-
13	vacuna	vacuna	NCFS000	C0042210	producto#sustancia	68-74	651_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
14	.	.	Fp	-	-	74-75	651_ANS_clinical_caseMIR	SENT1	-	-

1	Administrar	administrar	VMN0000	C1621583	calificador	0-11	651_ANS_clinical_caseMIR	SENT2	-	-
2	una	una		C0205447_1	calificador_1	12-15	651_ANS_clinical_caseMIR	SENT2	-	-
3	dosis	dosis	NCFN000	-	-	16-21	651_ANS_clinical_caseMIR	SENT2	-	-
4	de	de	SPS00	C0332285	atributo	22-24	651_ANS_clinical_caseMIR	SENT2	-	-
5	gammaglobulina	gammaglobulina	NCFS000	C0017007	sustancia	25-39	651_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
6	frente	frente	RG	C1284847#C0016540#C0549224	estructura_corporal	40-46	651_ANS_clinical_caseMIR	SENT2	-	-
7	a	a	SPS00	-	-	47-48	651_ANS_clinical_caseMIR	SENT2	-	-
8	VHB	virus_de_la_hepatitis_b	NC00YL0	-	-	49-52	651_ANS_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
9	y	y	CC	C1706368	calificador	53-54	651_ANS_clinical_caseMIR	SENT2	-	-
10	vacunaci贸n	vacunaci贸n	NCFS000	C0205991#C0042196	procedimiento	55-65	651_ANS_clinical_caseMIR	SENT2	-	-
11	completa	completo	AQ0FS0	C0205197#C0439810#C0444868	calificador	66-74	651_ANS_clinical_caseMIR	SENT2	-	-
12	.	.	Fp	-	-	74-75	651_ANS_clinical_caseMIR	SENT2	-	-

1	Administrar	administrar	VMN0000	C1621583	calificador	0-11	651_ANS_clinical_caseMIR	SENT3	-	-
2	una	una		C0205447_1	calificador_1	12-15	651_ANS_clinical_caseMIR	SENT3	-	-
3	dosis	dosis	NCFN000	-	-	16-21	651_ANS_clinical_caseMIR	SENT3	-	-
4	de	de	SPS00	C0332285	atributo	22-24	651_ANS_clinical_caseMIR	SENT3	-	-
5	gammaglobulina	gammaglobulina	NCFS000	C0017007	sustancia	25-39	651_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
6	frente	frente	RG	C1284847#C0016540#C0549224	estructura_corporal	40-46	651_ANS_clinical_caseMIR	SENT3	-	-
7	a	a	SPS00	-	-	47-48	651_ANS_clinical_caseMIR	SENT3	-	-
8	VHB	virus_de_la_hepatitis_b	NC00YL0	-	-	49-52	651_ANS_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
9	y	y	CC	C1706368	calificador	53-54	651_ANS_clinical_caseMIR	SENT3	-	-
10	realizar	realizar	VMN0000	-	-	55-63	651_ANS_clinical_caseMIR	SENT3	-	-
11	antisepsia	antisepsia	NCFS000	-	-	64-74	651_ANS_clinical_caseMIR	SENT3	-	-
12	de	de	SPS00	C0332285	atributo	75-77	651_ANS_clinical_caseMIR	SENT3	-	-
13	la	el	DA0FS0	-	-	78-80	651_ANS_clinical_caseMIR	SENT3	-	-
14	zona	zona	NCFS000	C0019360	trastorno	81-85	651_ANS_clinical_caseMIR	SENT3	-	-
15	.	.	Fp	-	-	85-86	651_ANS_clinical_caseMIR	SENT3	-	-

1	Realizar	realizar	VMN0000	-	-	0-8	651_ANS_clinical_caseMIR	SENT4	-	-
2	antisepsia	antisepsia	NCFS000	-	-	9-19	651_ANS_clinical_caseMIR	SENT4	-	-
3	de	de	SPS00	C0332285	atributo	20-22	651_ANS_clinical_caseMIR	SENT4	-	-
4	la	el	DA0FS0	-	-	23-25	651_ANS_clinical_caseMIR	SENT4	-	-
5	zona	zona	NCFS000	C0019360	trastorno	26-30	651_ANS_clinical_caseMIR	SENT4	-	-
6	y	y	CC	C1706368	calificador	31-32	651_ANS_clinical_caseMIR	SENT4	-	-
7	vacunaci贸n	vacunaci贸n	NCFS000	C0205991#C0042196	procedimiento	33-43	651_ANS_clinical_caseMIR	SENT4	-	-
8	completa	completo	AQ0FS0	C0205197#C0439810#C0444868	calificador	44-52	651_ANS_clinical_caseMIR	SENT4	-	-
9	.	.	Fp	-	-	52-53	651_ANS_clinical_caseMIR	SENT4	-	-

